FAST NEWS: Antengene Appoints New Chief Medical Officer
The latest: Biopharmaceutical company Antengene Corp. Ltd. (6996.HK) said on Wednesday Kevin Patrick Lynch has resigned as an executive director and chief medical officer (CMO) to retire, but will remain…
Recent Articles
RELATED ARTICLES
-
Can Haidilao learn from a busboy-turned-bubble tea magnate?
6862.HK
- Carote cooks up big growth with own-brand strategy
-
A new definition for independent directors – Part 2
0388.HK
- Mao Geping dolls up for Hong Kong IPO
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
- Payment app Lianlian seeks IPO relief from cash crunch
Discover hidden China stock gems in our weekly newsletter